Jubilant Ingrevia Share Price
Jubilant Ingrevia Share Price Today
As of 25 Jul 2026, Jubilant Ingrevia share price is ₹725.55. The stock opened at ₹745.00, compared to its previous close of ₹745.05. During today's trading session, Jubilant Ingrevia share price moved in the range of ₹723.00 to ₹745.05, with an average price of ₹734.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹537.30 and a high of ₹845.55. On the performance front, Jubilant Ingrevia share price has increased by 13.62% over the last six months and is down 11.43% on a year-on-year basis.
Jubilant Ingrevia Returns Calculator
Jubilant Ingrevia Shareholder Returns
Jubilant Ingrevia Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Pidilite Industries | 1,59,243.00 | 53.44 | 12.08 | 24.00% | 0.03 | 31.01% | 12.27 | 0.89% | 1.18 | 23.43 |
| SRF | 77,724.10 | 35.95 | 5.54 | 13.07% | 0.27 | 13.18% | 426.52 | 0.34% | 0.65 | 58.18 |
| Linde India | 57,247.20 | 105.77 | 13.61 | 13.58% | 0.02 | 17.78% | 13.74 | 0.18% | 0.56 | 64.59 |
| Gujarat Fluorochemicals | 50,257.50 | 87.56 | 6.43 | 7.30% | 0.22 | 8.93% | 647.24 | 0.07% | 0.59 | 61.69 |
| Godrej Industries | 45,319.90 | 18.79 | 4.05 | 11.10% | 6.08 | 9.34% | 14.24 | 0.00% | 0.73 | 1.81 |
| Navin Fluorine | 39,395.70 | 47.56 | 7.94 | 20.11% | 0.02 | 20.40% | 8.61 | 0.14% | 0.60 | 96.03 |
| Himadri Speciality Chemicals | 39,228.10 | 48.78 | 8.33 | 15.96% | 0.16 | 19.45% | 91.62 | 0.10% | 0.75 | 15.05 |
| Deepak Nitrite | 22,548.50 | 31.90 | 3.01 | 9.81% | 0.02 | 11.34% | 5.46 | 0.58% | 0.79 | 13.85 |
| Deepak Fertilizers & Petr | 19,838.90 | 27.00 | 2.91 | 10.77% | 0.23 | 10.76% | 290.01 | 0.63% | 0.44 | 21.33 |
| Aether Industries | 19,043.00 | 86.75 | 7.75 | 8.94% | 0.15 | 10.61% | 181.55 | 0.00% | 0.38 | 13.09 |
Jubilant Ingrevia Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹4,177.62 | ₹4,135.80 | ₹4,772.69 | ₹4,949.36 |
| Other Income | ₹37.82 | ₹35.30 | ₹33.37 | ₹31.49 |
| Total Revenue | ₹4,215.43 | ₹4,171.10 | ₹4,806.06 | ₹4,980.85 |
| Total Expenses | ₹3,871.79 | ₹3,903.51 | ₹4,369.31 | ₹4,271.86 |
| Profit Before Tax | ₹343.62 | ₹267.61 | ₹436.71 | ₹708.94 |
| Tax | ₹92.44 | ₹84.72 | ₹129.22 | ₹232.23 |
| Profit After Tax | ₹251.18 | ₹182.89 | ₹307.50 | ₹476.71 |
| EPS - Basic | ₹15.89 | ₹11.56 | ₹19.34 | ₹29.98 |
| EPS - Diluted | ₹15.84 | ₹11.55 | ₹19.33 | ₹29.97 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹343.62 | ₹267.61 | ₹436.71 | ₹708.94 |
| Income before WC changes | ₹564.88 | ₹470.12 | ₹584.99 | ₹882.06 |
| Change in Assets | -₹39.53 | ₹38.02 | -₹11.84 | -₹404.04 |
| Change in Liabilities | ₹62.33 | -₹32.15 | -₹33.31 | ₹102.83 |
| Change in WC | ₹22.79 | ₹5.87 | -₹45.15 | -₹301.22 |
| Cash flow from Operations | ₹508.10 | ₹429.98 | ₹462.46 | ₹452.74 |
| Cash flow from Investing | -₹392.82 | -₹568.78 | -₹471.89 | -₹71.86 |
| Cash flow from Financing | -₹128.76 | ₹144.13 | ₹41.60 | -₹417.75 |
| Total Cash Flow | -₹9.43 | ₹6.06 | ₹35.12 | -₹35.73 |
| Cash (Start of the year) | ₹78.78 | ₹72.73 | ₹37.61 | ₹73.34 |
| Cash (End of the year) | ₹69.36 | ₹78.78 | ₹72.73 | ₹37.61 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹3,178.54 | ₹2,951.99 | ₹2,440.88 | ₹2,032.58 |
| Current Assets | ₹1,853.23 | ₹1,779.90 | ₹1,818.00 | ₹1,764.57 |
| Total Assets | ₹5,031.77 | ₹4,731.89 | ₹4,258.88 | ₹3,797.15 |
| Current Liabilities | ₹1,401.00 | ₹1,286.08 | ₹1,179.58 | ₹1,052.78 |
| Net Current Asset | ₹452.23 | ₹493.83 | ₹638.43 | ₹711.79 |
| Non-Current Liabilities | ₹703.69 | ₹708.34 | ₹413.07 | ₹311.25 |
| Equity Capital | ₹2,927.08 | ₹2,737.47 | ₹2,666.23 | ₹2,433.12 |
| Total Equity & Liabilities | ₹5,031.77 | ₹4,731.89 | ₹4,258.88 | ₹3,797.15 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹3,941.22 | ₹3,987.25 | ₹4,559.58 | ₹4,860.42 |
| Other Income | ₹81.01 | ₹35.52 | ₹31.03 | ₹28.82 |
| Total Revenue | ₹4,022.23 | ₹4,022.77 | ₹4,590.60 | ₹4,889.24 |
| Total Expenses | ₹3,678.87 | ₹3,783.77 | ₹4,223.02 | ₹4,213.77 |
| Profit Before Tax | ₹343.37 | ₹239.00 | ₹367.58 | ₹675.47 |
| Tax | ₹79.94 | ₹76.55 | ₹114.17 | ₹223.22 |
| Profit After Tax | ₹263.43 | ₹162.45 | ₹253.41 | ₹452.25 |
| EPS - Basic | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 |
| EPS - Diluted | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹343.37 | ₹239.00 | ₹367.58 | ₹675.47 |
| Income before WC changes | ₹519.46 | ₹449.88 | ₹527.19 | ₹854.22 |
| Change in Assets | -₹45.93 | ₹40.39 | ₹6.57 | -₹351.52 |
| Change in Liabilities | ₹41.39 | -₹63.39 | -₹16.46 | ₹195.22 |
| Change in WC | -₹4.54 | -₹23.00 | -₹9.89 | -₹156.30 |
| Cash flow from Operations | ₹441.34 | ₹393.65 | ₹445.64 | ₹586.80 |
| Cash flow from Investing | -₹210.55 | -₹463.67 | -₹475.28 | -₹220.76 |
| Cash flow from Financing | -₹208.42 | ₹64.07 | ₹32.80 | -₹410.23 |
| Total Cash Flow | ₹22.37 | -₹5.96 | ₹3.16 | -₹44.19 |
| Cash (Start of the year) | ₹18.70 | ₹24.66 | ₹21.50 | ₹65.69 |
| Cash (End of the year) | ₹41.07 | ₹18.70 | ₹24.66 | ₹21.50 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,863.62 | ₹2,797.32 | ₹2,461.21 | ₹2,067.24 |
| Current Assets | ₹1,657.10 | ₹1,543.08 | ₹1,597.19 | ₹1,584.89 |
| Total Assets | ₹4,520.72 | ₹4,340.40 | ₹4,058.39 | ₹3,652.13 |
| Current Liabilities | ₹1,413.64 | ₹1,388.09 | ₹1,269.40 | ₹1,130.97 |
| Net Current Asset | ₹243.46 | ₹154.99 | ₹327.79 | ₹453.92 |
| Non-Current Liabilities | ₹666.21 | ₹705.25 | ₹630.42 | ₹538.11 |
| Equity Capital | ₹2,440.88 | ₹2,247.06 | ₹2,158.57 | ₹1,983.05 |
| Total Equity & Liabilities | ₹4,520.72 | ₹4,340.40 | ₹4,058.39 | ₹3,652.13 |
About Jubilant Ingrevia
Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
Jubilant Ingrevia Financial Highlights
- Revenue: Jubilant Ingrevia reported revenue of ₹4,428.60 crore in FY26 vs ₹4,215.43 crore in FY25. It showed an increase of 5.06% on a yearly basis.
- Operating Profit: Jubilant Ingrevia reported an operating profit of ₹369.75 crore in FY26 vs ₹343.61 crore in FY25. It showed an increase of 7.61% on a year-on-year basis.
- Net Profit: Jubilant Ingrevia reported a net profit of ₹277.91 crore in FY26 vs ₹251.17 crore in FY25. It showed an increase of 10.65% on a yearly basis.
Jubilant Ingrevia Quarterly Result Highlights
- Jubilant Ingrevia reported revenue of ₹1,310.49 crore in Jun 2026, compared with ₹1,187.96 crore in Mar 2026, representing an increase of 10.31% on a quarter-on-quarter (QoQ) basis.
- Jubilant Ingrevia reported an operating profit of ₹140.86 crore in Jun 2026, compared with ₹111.71 crore in Mar 2026, representing an increase of 26.09% on a quarter-on-quarter (QoQ) basis.
- Jubilant Ingrevia reported a profit of ₹105.82 crore in Jun 2026, compared with ₹86.44 crore in Mar 2026, reflecting an increase of 22.42% on a QoQ basis.
- The earnings per share (EPS) of Jubilant Ingrevia stood at ₹15.89 during Jun 2026.
Similar Stocks
FAQs on Jubilant Ingrevia Share Price
What is Jubilant Ingrevia share price today?
Jubilant Ingrevia share price is ₹725.55 as on 24 Jul, 2026, 15:50 IST.
How has the Jubilant Ingrevia share price performed in the past?
In the last 1 year, Jubilant Ingrevia delivered a return of -11.43%. The Jubilant Ingrevia share price hit a high of ₹845.55 and low of ₹537.30.
How much is the Mutual Fund shareholding in Jubilant Ingrevia shares?
The Mutual Fund Shareholding in Jubilant Ingrevia was 22.39% at the end of Jun 2026.
What is the the 52-week high and low of Jubilant Ingrevia shares ?
The 52-week high and low of Jubilant Ingrevia share is ₹845.55 and ₹537.30 as of 24 Jul, 2026.
What is the market cap of Jubilant Ingrevia?
The market capitalisation of Jubilant Ingrevia is ₹11,862.50 Crores as on 24 Jul, 2026.
What are the stock symbols of Jubilant Ingrevia?
The stock symbol of Jubilant Ingrevia is JUBLINGREA on the NSE, 543271 on the BSE, and the ISIN is INE0BY001018.
What was yesterday's closing price of Jubilant Ingrevia shares ?
Jubilant Ingrevia shares closed yesterday at ₹745.05 on NSE & ₹744.75 on BSE
How to buy Jubilant Ingrevia shares?
To buy Jubilant Ingrevia shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Jubilant Ingrevia shares on Holidays?
No, shares of Jubilant Ingrevia or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Jubilant Ingrevia shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Jubilant Ingrevia?
The PE and PB ratio of Jubilant Ingrevia is 38.43 and 3.79 respectively, as on 24 Jul, 2026, 15:50 IST.